Get a free sample of Breast Biopsy Devices Market
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Breast Biopsy Devices Market
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Breast Biopsy Devices Market Size
Breast Biopsy Devices Market size was valued at USD 1.8 billion in 2022 and is anticipated to register a CAGR of over 6.8% between 2023 and 2032. These devices are medical instruments or tools used by healthcare professionals to obtain tissue samples from the breast for diagnostic purposes. For instance, a report in the Journal of Clinical Oncology projects a 31% rise in new global female breast cancer cases, from 2,260,127 in 2020 to an estimated 2,964,197 cases in 2040.
Furthermore, an improved reimbursement landscape for breast biopsy procedures and associated diagnostic tests incentivizes healthcare providers and patients to utilize these services.
What is the size of the U.S. breast biopsy devices industry?
U.S. market accounted for USD 649 million in 2022 and is predicted to witness substantial growth through 2032, primarily due to the advanced healthcare infrastructure, widespread access to cutting-edge diagnostic technologies, and proactive breast cancer awareness programs.
How are hospitals influencing the demand for breast biopsy devices?
The hospitals segment generated USD 1.1 billion in 2022 and will continue to drive demand as these healthcare settings leverage advanced infrastructure and skilled professionals to integrate sophisticated biopsy procedures seamlessly, gaining patient
How big is the global breast biopsy devices market?
The global breast biopsy devices market was valued at USD 1.8 billion in 2022 and is estimated to reach USD 3.6 billion by 2032, backed by surge in breast cancer cases, favorable reimbursement policies, awareness about benefits of early detection.
Which companies define the competitive landscape of breast biopsy devices market?
Stryker Corporation, Boston Scientific Corporation, FUJIFILM Holdings Corporation, Argon Medical Devices, Inc, Hologic Inc, Cook Group Incorporated, Becton, Dickinson and Company (BD), Medtronic plc, Olympus Corporation, Cardinal Health, and INRAD Inc among others.